Sorrento Therapeutics has established a subsidiary in Mexico, Sorrento Therapeutics Mexico. The company was established for the clinical development and registration of a number of Sorrento products related to coronavirus. Sorrento Therapeutics Mexico has already received approval from the Mexican regulator to import into the country the first 25 million COVI-STIX tests.